Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Feature-weighted survival learning machine for COPD failure prediction.

Zhang J, Wang S, Courteau J, Chen L, Guo G, Vanasse A.

Artif Intell Med. 2019 May;96:68-79. doi: 10.1016/j.artmed.2019.01.003. Epub 2019 Mar 28.

PMID:
31164212
2.

Greater eosinophil counts at first COPD hospitalization are associated with more readmissions and fewer deaths.

Li Q, Larivée P, Courteau J, Couillard S, Poder TG, Carrier N, Bélanger M, Vanasse A.

Int J Chron Obstruct Pulmon Dis. 2019 Jan 30;14:331-341. doi: 10.2147/COPD.S187375. eCollection 2019.

3.

Eosinophil counts in first COPD hospitalizations: a 1-year cost analysis in Quebec, Canada.

Poder TG, Carrier N, Bélanger M, Couillard S, Courteau J, Larivée P, Vanasse A.

Int J Chron Obstruct Pulmon Dis. 2018 Oct 8;13:3065-3076. doi: 10.2147/COPD.S170747. eCollection 2018.

4.

Eosinophil counts in first COPD hospitalizations: a comparison of health service utilization.

Bélanger M, Couillard S, Courteau J, Larivée P, Poder TG, Carrier N, Girard K, Vézina FA, Vanasse A.

Int J Chron Obstruct Pulmon Dis. 2018 Oct 1;13:3045-3054. doi: 10.2147/COPD.S170743. eCollection 2018.

5.

[Initiating an antipsychotic drug treatment for schizophrenia: the situation in Quebec, Canada, from 1998 to 2006].

Carrier JD, Blais L, Cohen A, Courteau J, Roberge P, Larouche A, Grignon S, Fleury MJ, Lesage A, Demers MF, Roy MA, Delorme A, Vanasse A.

Sante Ment Que. Spring 2017;42(1):85-103. French.

PMID:
28792563
6.
7.

Predicting One-year Mortality After a "First" Hospitalization for Chronic Obstructive Pulmonary Disease: An Eight-Variable Assessment Score Tool.

Vanasse A, Courteau J, Couillard S, Beauchesne MF, Larivée P.

COPD. 2017 Oct;14(5):490-497. doi: 10.1080/15412555.2017.1343814. Epub 2017 Jul 26.

PMID:
28745528
8.

Eosinophils in COPD Exacerbations Are Associated With Increased Readmissions.

Couillard S, Larivée P, Courteau J, Vanasse A.

Chest. 2017 Feb;151(2):366-373. doi: 10.1016/j.chest.2016.10.003. Epub 2016 Oct 13.

PMID:
27746201
9.
10.

Comparative effectiveness and safety of antipsychotic drugs in schizophrenia treatment: a real-world observational study.

Vanasse A, Blais L, Courteau J, Cohen AA, Roberge P, Larouche A, Grignon S, Fleury MJ, Lesage A, Demers MF, Roy MA, Carrier JD, Delorme A.

Acta Psychiatr Scand. 2016 Nov;134(5):374-384. doi: 10.1111/acps.12621. Epub 2016 Jul 12.

PMID:
27404582
11.

Association between Floods and Acute Cardiovascular Diseases: A Population-Based Cohort Study Using a Geographic Information System Approach.

Vanasse A, Cohen A, Courteau J, Bergeron P, Dault R, Gosselin P, Blais C, Bélanger D, Rochette L, Chebana F.

Int J Environ Res Public Health. 2016 Jan 28;13(2):168. doi: 10.3390/ijerph13020168.

12.
13.

Neighbourhood immigration, health care utilization and outcomes in patients with diabetes living in the Montreal metropolitan area (Canada): a population health perspective.

Vanasse A, Courteau J, Orzanco MG, Bergeron P, Cohen AA, Niyonsenga T.

BMC Health Serv Res. 2015 Apr 9;15:146. doi: 10.1186/s12913-015-0824-1.

14.

Inclusion probability with dropout: an operational formula.

Milot E, Courteau J, Crispino F, Mailly F.

Forensic Sci Int Genet. 2015 May;16:71-76. doi: 10.1016/j.fsigen.2014.11.023. Epub 2014 Dec 4.

PMID:
25559642
15.

Health inequalities associated with neighbourhood deprivation in the Quebec population with hypertension in primary prevention of cardiovascular disease.

Vanasse A, Courteau J, Asghari S, Leroux D, Cloutier L.

Chronic Dis Inj Can. 2014 Nov;34(4):181-94. English, French.

16.

Beta-blockers are associated with increased risk of first cardiovascular events in non-diabetic hypertensive elderly patients.

Brouwers FM, Courteau J, Cohen AA, Farand P, Cloutier L, Asghari S, Vanasse A.

Pharmacoepidemiol Drug Saf. 2014 Nov;23(11):1139-46. doi: 10.1002/pds.3675. Epub 2014 Jul 5.

PMID:
25045055
17.

Improving the selection of true incident cases of low back pain by screening retrospective administrative data.

Beaudet N, Courteau J, Sarret P, Vanasse A.

Eur J Pain. 2014 Aug;18(7):923-31. doi: 10.1002/j.1532-2149.2013.00437.x. Epub 2013 Dec 16.

PMID:
24343901
18.

The adequacy of pharmaceutical treatment of schizophrenia in Quebec varies with age, but is not influenced by sex or neighbourhood deprivation.

Brouwers FM, Courteau J, Grégoire JP, Moisan J, Lauzier S, Lesage A, Fleury MJ, Vanasse A.

Can J Psychiatry. 2013 Aug;58(8):456-65.

PMID:
23972107
19.

Prevalence of claims-based recurrent low back pain in a Canadian population: a secondary analysis of an administrative database.

Beaudet N, Courteau J, Sarret P, Vanasse A.

BMC Musculoskelet Disord. 2013 Apr 29;14:151. doi: 10.1186/1471-2474-14-151.

20.

Does elapsed time between first diagnosis of schizophrenia and migration between health territories vary by place of residence? A survival analysis approach.

Ngamini Ngui A, Cohen AA, Courteau J, Lesage A, Fleury MJ, Grégoire JP, Moisan J, Vanasse A.

Health Place. 2013 Mar;20:66-74. doi: 10.1016/j.healthplace.2012.12.003. Epub 2013 Jan 7.

PMID:
23376731
21.

[Health inequities in mood disorders based on material and social deprivation in dwelling sectors ].

Vanasse A, Courteau J, Lesage A, Fleury MJ, Grégoire JP, Moisan J, Lauzier S, Bergeron C.

Can J Psychiatry. 2012 Dec;57(12):772-81. French.

PMID:
23228237
22.

Validating metabolic syndrome through principal component analysis in a medically diverse, realistic cohort.

Dusseault-Belanger F, Cohen AA, Hivert MF, Courteau J, Vanasse A.

Metab Syndr Relat Disord. 2013 Feb;11(1):21-8. doi: 10.1089/met.2012.0094. Epub 2012 Sep 14.

PMID:
22978288
23.

The interactive atlas on health inequalities.

Vanasse A, Courteau J, Courteau M.

Spat Spatiotemporal Epidemiol. 2012 Jun;3(2):129-40. doi: 10.1016/j.sste.2012.04.006. Epub 2012 Apr 27.

PMID:
22682439
24.

Modified metabolic syndrome criteria for identification of patients at risk of developing diabetes and coronary heart diseases: longitudinal assessment via electronic health records.

Hivert MF, Dusseault-Bélanger F, Cohen A, Courteau J, Vanasse A.

Can J Cardiol. 2012 Nov-Dec;28(6):744-9. doi: 10.1016/j.cjca.2012.02.009. Epub 2012 May 1.

PMID:
22552176
25.

Secular trends of hip fractures in Québec, Canada.

Vanasse A, Orzanco MG, Dagenais P, Ouarda T, Courteau J, Asghari S, Chebana F, Martel B, Gosselin P.

Osteoporos Int. 2012 Jun;23(6):1665-72. doi: 10.1007/s00198-011-1749-0. Epub 2011 Aug 30.

PMID:
21877202
26.

Attractiveness of family medicine for medical students: influence of research and debt.

Vanasse A, Orzanco MG, Courteau J, Scott S.

Can Fam Physician. 2011 Jun;57(6):e216-27.

27.

[The ambulatory care of the acute myocardial infarction in Quebec: description, classification and typology].

Gentil L, Vanasse A, Xhignesse M, Courteau J, Bérubé S.

Ann Cardiol Angeiol (Paris). 2011 Aug;60(4):183-8. doi: 10.1016/j.ancard.2011.04.001. Epub 2011 May 12. French.

PMID:
21658674
28.

Specialized cardiological care may be overutilized in urban areas of Quebec.

Cohen AA, Vanasse A, Courteau J; PRIMUS research group.

Eur J Prev Cardiol. 2012 Aug;19(4):731-7. doi: 10.1177/1741826711413371. Epub 2011 Jun 3.

PMID:
21642321
29.

Treatment prevalence and incidence of schizophrenia in Quebec using a population health services perspective: different algorithms, different estimates.

Vanasse A, Courteau J, Fleury MJ, Grégoire JP, Lesage A, Moisan J.

Soc Psychiatry Psychiatr Epidemiol. 2012 Apr;47(4):533-43. doi: 10.1007/s00127-011-0371-y. Epub 2011 Mar 29.

PMID:
21445625
30.

Rural-urban disparities in the management and health issues of chronic diseases in Quebec (Canada) in the early 2000s.

Vanasse A, Courteau J, Cohen AA, Orzanco MG, Drouin C.

Rural Remote Health. 2010 Oct-Dec;10(4):1548. Epub 2010 Oct 27.

31.

Adherence to vascular protection drugs in diabetic patients in Quebec: a population-based analysis.

Asghari S, Courteau J, Drouin C, Grégoire JP, Carpentier AC, Pâquet M, Vanasse A.

Diab Vasc Dis Res. 2010 Apr;7(2):167-71. doi: 10.1177/1479164109360593. Epub 2010 Feb 18.

PMID:
20382781
32.

Stroke and cardiovascular morbidity and mortality associated with rosiglitazone use in elderly diabetic patients.

Vanasse A, Carpentier AC, Courteau J, Asghari S.

Diab Vasc Dis Res. 2009 Apr;6(2):87-93. doi: 10.1177/1479164109336047.

PMID:
20368198
33.

Disparities between rural and urban areas for osteoporosis management in the province of Quebec following the Canadian 2002 guidelines publication.

Dagenais P, Vanasse A, Courteau J, Orzanco MG, Asghari S.

J Eval Clin Pract. 2010 Jun;16(3):438-44. doi: 10.1111/j.1365-2753.2009.01127.x. Epub 2010 Mar 10.

PMID:
20337832
34.

Optimal strategy to identify incidence of diagnostic of diabetes using administrative data.

Asghari S, Courteau J, Carpentier AC, Vanasse A.

BMC Med Res Methodol. 2009 Aug 28;9:62. doi: 10.1186/1471-2288-9-62.

35.

Cardiovascular safety of celecoxib in acute myocardial infarction patients: a nested case-control study.

Vanasse A, de Brum-Fernandes AJ, Courteau J.

Heart Int. 2009 Jun 30;4(1):e10. doi: 10.4081/hi.2009.e10.

36.

Canadian family physicians' intentions to migrate: associated factors.

Vanasse A, Scott S, Courteau J, Orzanco MG.

Can Fam Physician. 2009 Apr;55(4):396-397.e6.

37.
38.

Evaluation of clinical innovation: a gray zone in the ethics of modern clinical practice?

Patenaude J, Grant AM, Xhignesse M, Leblanc F, Courteau J.

J Gen Intern Med. 2008 Jan;23 Suppl 1:27-31. doi: 10.1007/s11606-007-0410-2.

39.

Long term regional migration patterns of physicians over the course of their active practice careers.

Vanasse A, Ricketts TC, Courteau J, Orzanco MG, Randolph R, Asghari S.

Rural Remote Health. 2007 Oct-Dec;7(4):812. Epub 2007 Nov 15.

40.

Myocardial infarction in Québec rural and urban populations between 1995 and 1997.

Loslier J, Vanasse A, Niyonsenga T, Courteau J, Orzanco G, Hemiari A.

Can J Rural Med. 2007 Spring;12(2):95-102.

PMID:
17442137
41.

[Are obesity, eating habits and sadentarism inseparable?].

Vanasse A, Demers M, Hemiari A, Courteau J.

Med Sci (Paris). 2007 Jan;23(1):5-6. French. No abstract available.

43.

Access to myocardial revascularization procedures: closing the gap with time?

Vanasse A, Niyonsenga T, Courteau J, Hemiari A.

BMC Public Health. 2006 Mar 8;6:60.

44.

Obesity in Canada: where and how many?

Vanasse A, Demers M, Hemiari A, Courteau J.

Int J Obes (Lond). 2006 Apr;30(4):677-83.

PMID:
16276358
45.

Spatial variation in the management and outcomes of acute coronary syndrome.

Vanasse A, Niyonsenga T, Courteau J, Grégoire JP, Hemiari A, Loslier J, Bénié G.

BMC Cardiovasc Disord. 2005 Jul 11;5(1):21.

46.

Bone mineral density measurement and osteoporosis treatment after a fragility fracture in older adults: regional variation and determinants of use in Quebec.

Vanasse A, Dagenais P, Niyonsenga T, Grégoire JP, Courteau J, Hemiari A.

BMC Musculoskelet Disord. 2005 Jun 21;6:33.

47.

Sex ratio evolution through group selection using diffusion approximation.

Courteau J, Lessard S.

J Math Biol. 2004 Mar;48(3):340-56. Epub 2003 Oct 27.

PMID:
14991236
48.

Smoking cessation within the context of family medicine: which smokers take action?

Vanasse A, Niyonsenga T, Courteau J.

Prev Med. 2004 Mar;38(3):330-7.

PMID:
14766116
49.

Family history and the risk of coronary heart disease: comparing predictive models.

Ciampi A, Courteau J, Niyonsenga T, Xhignesse M, Lussier-Cacan S, Roy M.

Eur J Epidemiol. 2001;17(7):609-20.

PMID:
12086074
50.

Supplemental Content

Loading ...
Support Center